Aperio Group’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$7.42M Sell
178,433
-13,547
-7% -$565K 0.02% 664
2020
Q3
$8.15M Buy
191,980
+3,398
+2% +$147K 0.03% 546
2020
Q2
$8.16M Sell
188,582
-19,544
-9% -$772K 0.03% 534
2020
Q1
$6.83M Buy
208,126
+33,728
+19% +$1.25M 0.03% 540
2019
Q4
$6.42M Sell
174,398
-8,061
-4% -$286K 0.02% 644
2019
Q3
$6.13M Sell
182,459
-23,202
-11% -$822K 0.02% 642
2019
Q2
$8.08M Buy
205,661
+8,566
+4% +$339K 0.03% 546
2019
Q1
$7.99M Buy
197,095
+3,296
+2% +$123K 0.03% 529
2018
Q4
$6.28M Sell
193,799
-47,312
-20% -$1.91M 0.03% 555
2018
Q3
$12.4M Sell
241,111
-13,853
-5% -$693K 0.05% 376
2018
Q2
$12.8M Buy
254,964
+15,616
+7% +$792K 0.06% 356
2018
Q1
$12.2M Buy
239,348
+20,208
+9% +$1.08M 0.06% 367
2017
Q4
$11.5M Buy
219,140
+8,210
+4% +$408K 0.06% 383
2017
Q3
$10.3M Buy
210,930
+13,420
+7% +$638K 0.06% 386
2017
Q2
$9.55M Buy
197,510
+10,302
+6% +$474K 0.06% 389
2017
Q1
$7.89M Buy
187,208
+6,009
+3% +$248K 0.05% 402
2016
Q4
$7.65M Sell
181,199
-50,151
-22% -$2.05M 0.06% 380
2016
Q3
$10.1M Buy
231,350
+3,380
+1% +$151K 0.07% 316
2016
Q2
$9.93M Sell
227,970
-14,424
-6% -$622K 0.08% 298
2016
Q1
$10.7M Sell
242,394
-4,992
-2% -$211K 0.09% 260
2015
Q4
$10.4M Buy
247,386
+10,736
+5% +$452K 0.09% 244
2015
Q3
$9.23M Sell
236,650
-8,720
-4% -$355K 0.09% 259
2015
Q2
$10.2M Buy
245,370
+23,381
+11% +$999K 0.11% 236
2015
Q1
$9.2M Buy
221,989
+11,455
+5% +$442K 0.1% 240
2014
Q4
$7.82M Buy
210,534
+34,209
+19% +$1.23M 0.1% 254
2014
Q3
$6.12M Buy
176,325
+41,194
+30% +$1.42M 0.08% 304
2014
Q2
$4.53M Sell
135,131
-36,583
-21% -$1.22M 0.07% 362
2014
Q1
$5.98M Buy
+171,714
New +$6.01M 0.08% 302
2013
Q4
Sell
-115,161
Closed -$3.86M 329
2013
Q3
$3.73M Sell
115,161
-7,548
-6% -$246K 0.07% 360
2013
Q2
$4.33M Buy
+122,709
New +$4.27M 0.1% 241

Other funds holding FMS

Aperio Group's FMS Position: Q4 2020 in Review

Aperio Group reduced its Fresenius Medical Care (FMS) stake by 7.1% in Q4 2020, selling an estimated $565K and leaving 178,433 shares worth $7.42M. The position accounts for 0.02% of the portfolio, ranked #664.

Aperio Group first reported a position in FMS in Q2 2013 and has held it in 30 quarters since. The position peaked at $12.8M in Q2 2018. 178 funds tracked by Wall St. Rank hold FMS as of Q4 2020.

  • Aperio Group held 178,433 shares of Fresenius Medical Care worth $7.42M as of Q4 2020.
  • Aperio Group sold 13,547 Fresenius Medical Care shares in Q4 2020, an estimated $565K.
  • Fresenius Medical Care made up 0.02% of Aperio Group's portfolio in Q4 2020, its #664 holding.
  • Aperio Group first reported a position in Fresenius Medical Care in Q2 2013 and has held it in 30 quarters since.
  • Aperio Group's Fresenius Medical Care position peaked at $12.8M in Q2 2018.
  • 178 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.